Abstract
Background and Objective: Single-unit solid oral dosage forms such as tablets and capsules are considered the most common and acceptable form of immediate release systemic drug delivery systems. On the other hand, multiple-unit pellet systems (MUPS) have in recent years become an important dosage form that offers various advantages over conventional single-unit solid oral dosage forms.
Discussion: These advantages include, amongst others, reduced risk of local irritation and toxicity, more predictable bioavailability, reduced likelihood of dose dumping and minimised fluctuations in the plasma concentration of the drug. MUPS comprise of relatively small uncoated or coated spherical particles (pellets or beads) compressed into tablets (MUPS tablets) or filled into hard gelatine capsules (MUPS capsules).
Conclusion: Application of MUPS technology has led to the successful formulation of various marketed products such as omeprazole in Losec® MUPS tablets, which has resulted in increased drug bioavailability and improved pharmacological response. Another application of MUPS technology is controlled drug release, for example theophylline MUPS capsules (Elixophyline®), which offer sustained drug release.
Keywords: Beads, drug delivery, extrusion-spheronisation, pellets, multiple-unit pellet system (MUPS), pharmacokinetic.
Drug Delivery Letters
Title:Multiple-Unit Pellet Systems (MUPS): Production and Applications as Advanced Drug Delivery Systems
Volume: 7 Issue: 3
Author(s): Hannlie Hamman, Josias Hamman and Jan Steenekamp*
Affiliation:
- Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Private Bag X6001, Potchefstroom,south africa
Keywords: Beads, drug delivery, extrusion-spheronisation, pellets, multiple-unit pellet system (MUPS), pharmacokinetic.
Abstract: Background and Objective: Single-unit solid oral dosage forms such as tablets and capsules are considered the most common and acceptable form of immediate release systemic drug delivery systems. On the other hand, multiple-unit pellet systems (MUPS) have in recent years become an important dosage form that offers various advantages over conventional single-unit solid oral dosage forms.
Discussion: These advantages include, amongst others, reduced risk of local irritation and toxicity, more predictable bioavailability, reduced likelihood of dose dumping and minimised fluctuations in the plasma concentration of the drug. MUPS comprise of relatively small uncoated or coated spherical particles (pellets or beads) compressed into tablets (MUPS tablets) or filled into hard gelatine capsules (MUPS capsules).
Conclusion: Application of MUPS technology has led to the successful formulation of various marketed products such as omeprazole in Losec® MUPS tablets, which has resulted in increased drug bioavailability and improved pharmacological response. Another application of MUPS technology is controlled drug release, for example theophylline MUPS capsules (Elixophyline®), which offer sustained drug release.
Export Options
About this article
Cite this article as:
Hamman Hannlie , Hamman Josias and Steenekamp Jan *, Multiple-Unit Pellet Systems (MUPS): Production and Applications as Advanced Drug Delivery Systems, Drug Delivery Letters 2017; 7 (3) . https://dx.doi.org/10.2174/2210303107666170927161351
DOI https://dx.doi.org/10.2174/2210303107666170927161351 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Two Cases of Double Pituitary Adenomas in a Surgical Series Over 16 Years in a Single Centre
Endocrine, Metabolic & Immune Disorders - Drug Targets Effect of Aqueous Extract of Azadirachta indica Leaves on Pharmacokineics and Pharmacodynamics of Glipizide
Drug Metabolism Letters Preface [ Infectious Disorders Drug Targets - An Arsenal of Knowledge on Pathogen Targets ]
Infectious Disorders - Drug Targets Gynecomastia in Infants, Children, and Adolescents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid
Current Pharmaceutical Design Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody
Anti-Cancer Agents in Medicinal Chemistry The Effect of Intranasal Oxytocin on Sexual Function in Men and Women: A Systematic Review
Current Drug Therapy Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Current Pharmaceutical Design Orexigenic / Anorexigenic Signals in Bulimia Nervosa
Current Molecular Medicine Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Current Concepts Underlying Benefits of Exercise Training in Congestive Heart Failure Patients
Current Cardiology Reviews Synthetic Thiazolidinediones: Potential Antidiabetic Compounds
Current Organic Chemistry The Current Use of Mass Spectrometry in Combination with Other Separation Techniques in Drug Discovery Arena
Medicinal Chemistry Thermostable Glycoside Hydrolases in Biorefinery Technologies
Current Biotechnology Nanoparticle and Stem Cell Combination Therapy for the Management of Stroke
Current Pharmaceutical Design The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured
Endocrine, Metabolic & Immune Disorders - Drug Targets Cell Death and Survival Through the Endoplasmic Reticulum- Mitochondrial Axis
Current Molecular Medicine Harnessing CD36 to Rein in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
Current Alzheimer Research